Carcinoma, Pancreatic Ductal
Information
- Disease name
- Carcinoma, Pancreatic Ductal
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02750657 | Active, not recruiting | Study of Changes and Characteristics of Genes in Patients With Pancreatic Cancer for Better Treatment Selection | December 2015 | December 2024 | |
| NCT00471146 | Completed | Phase 3 | Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer. | July 2007 | November 2010 |
| NCT00902291 | Completed | Phase 2 | A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer | April 2009 | April 2012 |
| NCT05723978 | Completed | Selective Extended Dissection in Different Types of Pancreatic Head Cancer: A Retrospective Cohort Study. | January 1, 2011 | December 1, 2022 | |
| NCT04146441 | Completed | Phase 2 | Ultrasound-enhanced Uptake of Chemotherapy in Patients With Inoperable Pancreatic Ductal Adenocarcinoma | February 10, 2020 | December 31, 2022 |
| NCT01478685 | Completed | Phase 1 | A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors | November 29, 2011 | November 17, 2015 |
| NCT01608711 | Completed | Phase 2 | A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002 | August 7, 2012 | November 16, 2015 |
| NCT01808638 | Completed | Phase 1/Phase 2 | Atu027 Plus Gemcitabine in Advanced or Metastatic Pancreatic Cancer (Atu027-I-02) | March 2013 | January 2016 |
| NCT02150746 | Completed | Circulating Tumor Cells in Operative Blood | February 2015 | February 2016 | |
| NCT03513705 | Completed | N/A | Impact of Nationwide Enhanced Implementation of Best Practices in Pancreatic Cancer Care (PACAP-1) | May 22, 2018 | July 9, 2021 |
| NCT02993731 | Completed | Phase 3 | A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma | December 2016 | March 2020 |
| NCT02933307 | Completed | N/A | Continuous Monitoring on the General Ward | April 2015 | September 2016 |
| NCT02658214 | Completed | Phase 1 | Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors | April 28, 2016 | November 14, 2019 |
| NCT02653313 | Completed | Phase 1/Phase 2 | Parvovirus H-1 (ParvOryx) in Patients With Metastatic Inoperable Pancreatic Cancer | December 2015 | May 2018 |
| NCT06447662 | Not yet recruiting | Phase 1 | A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation. | July 28, 2024 | July 12, 2028 |
| NCT05489458 | Not yet recruiting | Predictive Factors for Resection and Survival in Type A Borderline Resectable Pancreatic Ductal Adenocarcinoma Patients After Neoadjuvant Therapy | September 2022 | January 2023 | |
| NCT05621824 | Not yet recruiting | A Cohort Study on Screening and Follow-up of High-risk Population of PDAC Based on EUS | December 2024 | December 2028 | |
| NCT05461430 | Recruiting | Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) | July 15, 2022 | July 2026 | |
| NCT05475366 | Recruiting | N/A | Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures | December 12, 2022 | December 11, 2026 |
| NCT03403101 | Recruiting | Phase 2 | The Combination Chemotherapy of SIRIOX as First- or Second-Line Chemotherapy for Pancreatic Cancer | July 1, 2020 | July 1, 2024 |
| NCT02456051 | Terminated | Pancreatic Cancer Can be Detected by Adrenomedullin in New Onset Diabetes Patients | April 2015 | November 2017 | |
| NCT01413451 | Terminated | Early Phase 1 | Amatuximab for High Mesothelin Cancers | July 12, 2011 | November 15, 2013 |
| NCT01394120 | Unknown status | Phase 2 | Chemotherapy Selection Based on Therapeutic Targets for Advanced Pancreatic Cancer | August 2011 | December 2013 |
| NCT02817308 | Unknown status | N/A | Correlation of Serum CA19-9 Levels With Levels in Saliva and Urine of Patients With Ductal Adenocarcinoma of the Pancreas | July 2016 | January 2020 |
| NCT02451384 | Unknown status | N/A | According CTC to Compare the Influences of Different Methods to Remove the PDAC | June 2015 | December 2016 |
| NCT03432624 | Unknown status | Detection of MicroRNA-25 in the Diagnosis of Pancreatic Cancer | March 1, 2018 | January 1, 2019 | |
| NCT03500068 | Unknown status | N/A | Establishing Organoids From Metastatic Pancreatic Cancer Patients, the OPT-I Study. | September 4, 2017 | September 1, 2022 |
| NCT02310230 | Unknown status | N/A | An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy | September 2014 | December 2016 |
| NCT02928081 | Unknown status | N/A | Standard Versus Extended Lymphadenectomy in Pancreatoduodenectomy for Patients With Pancreatic Head Adenocarcinoma | January 2016 | April 2021 |
| NCT02529579 | Unknown status | Phase 1/Phase 2 | Safety and Efficacy Evaluation of iAPA-DC/CTL Combined Gemcitabine Therapy on Advanced Pancreatic Cancer | June 2015 | December 2019 |
| NCT00226746 | Withdrawn | Phase 2 | Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic Cancer | March 2003 | June 2012 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D021441